4.3 Review

Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Siglecs as targets for therapy in immune-cell-mediated disease

Mary K. O'Reilly et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2009)

Article Chemistry, Multidisciplinary

Sialoside analogue arrays for rapid identification of high affinity siglec ligands

Ola Blixt et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)

Article Biochemistry & Molecular Biology

Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity

Hiroaki Tateno et al.

MOLECULAR AND CELLULAR BIOLOGY (2007)

Review Immunology

Siglecs and their roles in the immune system

Paul R. Crocker et al.

NATURE REVIEWS IMMUNOLOGY (2007)

Article Medicine, General & Internal

Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia

RJ Kreitman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)